Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder

Completed · Phase 3

Conditions studied: Bipolar Disorder

In brief

This purpose of this study is to evaluate the safety and efficacy of Licarbazepine for the treatment of manic episodes of bipolar disorder.

Key facts

Study ID

NCT00099229

Run by

Novartis Pharmaceuticals

People needed

320

Starts

2004-11-01

Expected to finish

2006-08-01

Last updated by the study team

2017-02-23

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of bipolar disorder (type I) with manic or mixed episodes (including patients with/without psychotic features or with/without a history of rapid cycling)
• In need of psychiatric treatment
• Cooperation and willingness to complete all aspects of the study

You may not qualify if…

• Current diagnosis other than bipolar I disorder
• History of schizophrenia or schizoaffective disorder
• Drug dependence within 1 month prior to study start or testing positive in a urine drug test
• Suicide attempt within 1 month prior to study start or at immediate risk of harm to self or others
• Any form of psychotherapy within 1 month prior to study start

Where it is running

• Investigational Site — Little Rock, Arkansas, United States
• Investigational Site — Cerritos, California, United States
• Investigational Site — San Diego, California, United States
• Investigational Site — Port Charlotte, Florida, United States
• Investigational Site — Indianapolis, Indiana, United States
• Investigational Site — Newton, Kansas, United States
• Investigational Site — Las Vegas, Nevada, United States
• Investigational Site — Raleigh, North Carolina, United States
• Investigational Site — Cincinnati, Ohio, United States
• Investigational Site — Oklahoma City, Oklahoma, United States
• Investigational Site — Philadelphia, Pennsylvania, United States
• Investigational Site — Austin, Texas, United States
• Investigational Site — Bellaire, Texas, United States
• Investigational Site — Houston, Texas, United States
• Investigational Site — Houston, Texas, United States
• Investigational Site — Kirkland, Washington, United States
• Investigational Site — Dijon, France
• Investigational Site — Strasbourg, France
• Investigational Site — Moscow, Russia
• Investigational Site — Moscow, Russia
• Investigational Site — Moscow, Russia
• Investigational Site — Saint Petersburg, Russia

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.